Facial EMG activity levels predict treatment outcome in depression.
Higher electromyographic (EMG) activity levels of corrugator and zygomatic face muscles have been reported to be pretreatment predictors of better clinical outcome in depressed patients. We tested this possibility in 29 drug-free, rigorously diagnosed subjects by measuring low-level EMG activity of corrugator and zygomatic muscles during resting and three imagery states (happy, typical day, sad). All patients had major depressive disorder, endogenous subtype. Good responders had significantly higher pretreatment EMG zygomatic values and different EMG profiles. Our findings replicate and expand prior reports.
D000639:Amitriptyline / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy / Q000523:psychology; D003866:Depressive Disorder / Q000188:drug therapy*; D003891:Desipramine / Q000627:therapeutic use; D004576:Electromyography / Q000379:methods*; D005149:Facial Expression; D005152:Facial Muscles / Q000187:drug effects*; D005260:Female; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008376:Maprotiline / Q000627:therapeutic use; D008875:Middle Aged; D009119:Muscle Contraction / Q000187:drug effects*; D011379:Prognosis; D011569:Psychiatric Status Rating Scales
D000928:Antidepressive Agents; D000639:Amitriptyline; D008376:Maprotiline; D007099:Imipramine; D003891:Desipramine